Bacil Pharma Limited has submitted a regulatory intimation to BSE Limited regarding an upcoming meeting of its Board of Directors.
The Board meeting is scheduled to be held on 29th August, 2026. The agenda for the meeting includes the following items:
- Discussion on the Notice for the Company's 39th Annual General Meeting
- Discussion and approval of the Director's Report for the Financial Year 2025-2026
- Discussion to fix the Date, Place, and Timing of the 39th Annual General Meeting of the Company
- Any other business with the permission of the Chairperson
The document was signed by Chaitali Kalpataru Shah, Director (DIN: 11167778), on behalf of the Board of Directors. The signing took place digitally on August 26, 2026, at 18:29:58 IST.
This intimation represents a routine regulatory disclosure regarding corporate governance matters and preparation for the company's annual general meeting process.